US Federal 2025-2026 Regular Session

US Federal House Bill HB3752

Introduced
6/5/25  
Refer
6/5/25  

Caption

Specialist Fourth Class Keith Smith Glioblastoma Parity Act of 2025

Impact

If enacted, this bill would facilitate access to healthcare benefits for affected veterans by recognizing glioblastoma multiforme as a condition presumed to be related to their service. This change is significant as it reflects a growing acknowledgment of the health consequences faced by Vietnam veterans due to Agent Orange exposure. By simplifying the process for veterans to claim these benefits, HB3752 would likely improve health outcomes for many individuals diagnosed with this aggressive form of cancer.

Summary

House Bill 3752, known as the 'Specialist Fourth Class Keith Smith Glioblastoma Parity Act of 2025', proposes to amend title 38 of the United States Code to establish a presumption of service connection for glioblastoma multiforme in veterans who served in specific locations during the Vietnam War. The bill builds on historical context, noting that between 1961 and 1971, significant amounts of herbicides, including Agent Orange, were sprayed in Vietnam, exposing millions of veterans to harmful chemicals and leading to long-term health effects.

Contention

Throughout discussions surrounding HB3752, there may be considerations about the adequacy and reliability of the scientific evidence linking glioblastoma to military service during the Vietnam era. Some legislators and advocacy groups might raise concerns about the implications of expanding presumption laws, including the potential for increased claims and costs associated with healthcare services. Nonetheless, supporters argue that acknowledging this presumption is a necessary step in recognizing and addressing the sacrifices made by veterans.

Companion Bills

No companion bills found.

Previously Filed As

US HB3052

Agent Orange Relief Act of 2025

US HB3051

Victims of Agent Orange Act of 2025

US SR285

A resolution designating July 16, 2025, as "Glioblastoma Awareness Day".

US HR394

Expressing support for the designation of July 16, 2025, as "Glioblastoma Awareness Day".

US H8099

Agent Orange Awareness Day

US HR303

Designating the month of October 2025 as "Agent Orange Awareness Month" in Pennsylvania.

US AJR51

Recognizes Orange Heart Medal in NJ.

US SJR71

Recognizes Orange Heart Medal in NJ.

US HJR0358

A RESOLUTION to honor the commemoration of National Glioblastoma Cancer Awareness Day in Tennessee.

US HR17

Veterans who were victims of Agent Orange during the Vietnam War; commend

Similar Bills

No similar bills found.